Verastem reported $108.76M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
AstraZeneca AZN:LN USD 20.22B 693M
Curis CRIS:US USD 105.72M 7.68M
Cytokinetics CYTK:US USD 884.28M 282.02M
Gilead Sciences GILD:US USD 13.9B 723M
Immunogen IMGN:US USD 330.42M 63.51M
Laboratory Of America LH:US USD 4.37B 659M
Novartis NOVN:VX USD 36.95B 1.19B
Roche Holding ROG:VX 30.32B 5.31B
Tg Therapeutics TGTX:US USD 182.92M 19.64M
Verastem VSTM:US USD 108.76M 10.88M
YTE INCY:US USD 3.82B 195.27M
Ziopharm Oncology ZIOP:US USD 55.5M 5.86M